Loading...

APUS APIMEDS PHARMACEUTICALS US INC Management Changes 8-K Filing

PMDS

PS

APIMEDS PHARMACEUTICALS US INC

(APUS)

2026 8-K

New CEO Appointment

Settlement Agreement

Delisting Notice

Filings Delay Notification

Stockholder Consent Nullified

Board Changes Invalidated

Board Restructuring

Stock Split Announcement

Director Resignations

Merger Amendment Notice

Merger Agreement

CEO Salary Increase

Bylaw Amendment

Investor Meetings

Debt Restructuring

External Links:

On December 30, 2025, stockholders of Apimeds Pharmaceuticals US, Inc. removed Erik Emerson from the board of directors, following the approval of the majority of voting shareholders.

AI Assistant

APIMEDS PHARMACEUTICALS US INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.